Close Menu

NEW YORK – DiaSorin Molecular announced Thursday its Simplexa COVID-19 Direct test has received CE marking for use with saliva samples.

The test previously received CE marking for use with nasal swabs, nasopharyngeal swabs, nasal wash and aspirates, and bronchoalveolar lavages. The addition of saliva samples will allow laboratories to increase capacity, overcome bottlenecks, and manage swab and transport media shortages, the company said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.